|
[Related PubMed/MEDLINE]
Total Number of Papers: 49
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: NSTE-ACS |
| Long Form |
: non-ST-segment elevation ACS |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Association Between Serum Galectin-3 Levels and Coronary Stenosis Severity in Patients With Coronary Artery Disease. |
ACS, CAD, Gal-3, MACEs, SSs, STEMI |
| 2 |
2022 |
Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease. |
ACS, adj, AUC, HR, MVD, PCR, ROC, STEMI |
| 3 |
2022 |
Clinical features and outcomes of patients with stable or unstable chest pain and no-obstructive coronary artery disease. |
ACh, ACS, SAQ |
| 4 |
2022 |
Diagnosis and Treatment of Acute Coronary Syndromes: A Review. |
ACS, NSTEMI, PCI, STEMI |
| 5 |
2022 |
Estimated glomerular filtration rate derived from different formulas and prognosis in acute coronary syndrome: Findings from the improving care for cardiovascular disease in China-acute coronary syndrome project. |
ACS, AUC, CKD-EPI, GFR, MDRD, STEMI |
| 6 |
2022 |
Multimorbidity and Readmissions in Older People with Acute Coronary Syndromes. |
ACS, OR, STEMI, TIA |
| 7 |
2022 |
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI. |
ACS, BARC, CI, HR, NACEs, STEMI |
| 8 |
2022 |
[Management of acute coronary syndrome without ST-segment elevation]. |
ACS, ESC, hs-cTn, NSTEMI, STEMI |
| 9 |
2021 |
Association between Plasma Thiol Parameters and Troponin Levels in Patients with Acute Coronary Syndrome and Prediction of In-Hospital Ventricular Arrhythmia. |
ACS, STE-ACS, TNTR, VAs |
| 10 |
2021 |
Characteristics and Outcomes of Patients With Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention During Snowy Days. |
ACS, DTB, PCI, STEMI |
| 11 |
2021 |
Nomogram to differentiate between aortic dissection and non-ST segment elevation acute coronary syndrome: a retrospective cohort study. |
ACS, AD, AUC, ECG, ED, LASSO, ROC |
| 12 |
2021 |
Outcomes of Nonagenarians With Acute Coronary Syndrome. |
ACS, CI, HR, MT, PCI, STEMI |
| 13 |
2021 |
Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre. |
ACS, AF, CVDs, ECG, STEMI |
| 14 |
2021 |
The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55). |
ACS, NZ, STEMI |
| 15 |
2021 |
Trends Over Time in the Incidences of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction During the Past Decade in a Rural Japanese High-Aged Population. |
ACS, NSTEMI, STEMI |
| 16 |
2020 |
Sex Differences in the Outcomes of Elderly Patients with Acute Coronary Syndrome. |
ACS |
| 17 |
2019 |
Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes. |
ACS, CAD, hs-CRP, sLOX-1 |
| 18 |
2019 |
Ticagrelor Does Not Improve Endothelial Dysfunction in Stable Survivors of Acute Coronary Syndrome. |
ACS, BAFMD |
| 19 |
2019 |
Value of Syntax Score II in Prediction of New-Onset Atrial Fibrillation in Patients With NSTE-ACS Undergoing Percutaneous Coronary Intervention. |
ACSs, NOAF, PCI, SS, SSII |
| 20 |
2018 |
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis. |
ACS, APT, DOAC, OR, STEMI |
| 21 |
2017 |
Evaluation of the relationship between renal resistive index and extent and complexity of coronary artery disease in patients with acute coronary syndrome. |
ACS, AT, CAD, LV, RPI, RRI, STE-ACS, SYNTAX |
| 22 |
2017 |
GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome. |
ACS, GRACE, RS, STEMI |
| 23 |
2017 |
Oral antiplatelet agents for the management of acute coronary syndromes: A review for nurses and allied healthcare professionals. |
ACS, NPs, OAP |
| 24 |
2017 |
Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome. |
ACS, STEMI |
| 25 |
2016 |
Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. |
ACS, STEMI |
| 26 |
2016 |
From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes. |
ACS, STEMI |
| 27 |
2016 |
Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry. |
ACS, CVD, HCRU, STEMI |
| 28 |
2015 |
A study of IgG antibodies to the ApoB protein in non-ST segment elevation acute coronary syndrome. |
ACS, apoB, ox-LDL |
| 29 |
2015 |
Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin. |
ACS, DES, G6PD, PCI |
| 30 |
2015 |
Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes. |
ACS, GPI, PCI, ST, STEMI, UFH |
| 31 |
2015 |
Managing the acute coronary syndrome patient: Evidence based recommendations for anti-platelet therapy. |
ACS, STEMI, UA |
| 32 |
2015 |
Sweating: A Specific Predictor of ST-Segment Elevation Myocardial Infarction Among the Symptoms of Acute Coronary Syndrome: Sweating In Myocardial Infarction (SWIMI) Study Group. |
ACS, CI, LR, PPV, STEMI, SWIMI |
| 33 |
2014 |
Association of nonculprit plaque characteristics with transient slow flow phenomenon during percutaneous coronary intervention. |
ACS, CI, LAP, MDCT, NRS, OR, PR, SF |
| 34 |
2014 |
Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. |
ACS, CAG, EAPCI, OHCA, SFL, STEMI |
| 35 |
2014 |
Usefulness of limited echocardiography with A-F mnemonic in patients with suspected non‑ST-segment elevation acute coronary syndrome. |
ACSs, TTE |
| 36 |
2013 |
Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study. |
ACE, ACS, OR, STEMI |
| 37 |
2013 |
Oral antiplatelet therapy in acute coronary syndromes: recent developments. |
ACS, PCI, STEMI |
| 38 |
2012 |
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes. |
ACS, CI, EES, HR, MI, SES, TVR |
| 39 |
2012 |
Prognostic value of B-type natriuretic peptide in the mortality of patients with acute coronary syndrome. |
ACS |
| 40 |
2011 |
Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I. |
ACS, cTnI, sRAGE |
| 41 |
2010 |
Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel. |
ACS, CRP, IL-6, MPO, sCD40L |
| 42 |
2010 |
Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. |
ACS |
| 43 |
2010 |
Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. |
ACSs, CI, KD, OR |
| 44 |
2009 |
Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions. |
ACS, cTnI, GP, MACE, PCI |
| 45 |
2009 |
Prognostic impact of types of atrial fibrillation in acute coronary syndromes. |
ACSs, AF |
| 46 |
2006 |
[Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event--temporal trends]. |
ACS, CRP, IL-6, TNF-alpha |
| 47 |
2005 |
A simplified approach to the management of non-ST-segment elevation acute coronary syndromes. |
ACS |
| 48 |
2005 |
Prognostic value of preoperative cardiac troponin I in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. |
ACS, CABG, CI, cTnI, MACE, OR |
| 49 |
2004 |
Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes. |
ACS |
|
A Search Service for Abbreviation / Long Form
